Safety and Efficacy of the ToothWave Power Toothbrush for Extrinsic Stain Reduction

September 9, 2019 updated by: Home Skinovations Ltd.
This study is a single blind, prospective study aimed to evaluate the safety and efficacy of the Silk'n ToothWave Power Toothbrush for stains reduction and improvement of teeth shade.

Study Overview

Status

Completed

Conditions

Detailed Description

The study includes 84 treatment sessions, twice a day, and 4 clinic visits over a period of 6 weeks.

One treatment group (Silk'n power toothbrush - ToothWave) and 1 control group (an ADA approved power toothbrush (PTB)) will participate in the study.

For each patient, efficacy assessment data will be collected at baseline, 4 weeks, and at 6 weeks. The average stain data will be calculated for each group.

Treatment is defined as a timed, 2 minute brushing of the teeth according to the manufactur-er's instructions, twice daily (morning and evening). Brushing will be undertaken using the Silk'n toothbrush and standard fluoride toothpaste. The control group will use an ADA ac-cepted PTB and the same standard fluoride toothpaste.

Study Type

Interventional

Enrollment (Actual)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Indiana
      • Fort Wayne, Indiana, United States, 46825
        • Salus Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Adult subjects aged 18-70, that are in good health.
  2. Subjects should have notable extrinsic dental stains on the front teeth with a total extrin-sic facial tooth stain score ≥14 according to the LSI.
  3. The subjects should understand the information provided about the investigative nature of the treatment, possible benefits and side effects. Subjects will sign the Informed Consent Form.
  4. The subjects should be willing to comply with the study procedure and schedule, includ-ing the follow up visits, and will refrain from using any other teeth whitening technologies during this period.
  5. The subject did not perform any procedure for teeth whitening (either at home or in clin-ic) at least 3 years prior to participating in the study

Exclusion Criteria:

  1. Any condition that might make it unsafe for the subject to participate in the study, at the discretion of the investigator
  2. Pacemaker or internal defibrillator, or any other active electrical implant anywhere in the body.
  3. Pregnant or nursing by subject report.
  4. Any active condition in the oral cavity at the discretion of the investigator.
  5. Any surgery in the treated area within 3 months prior to treatment, or before complete healing.
  6. Subjects that do not brush regularly.
  7. Regular tobacco smokers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment - toothwave brush
Subjects using the Silk'n ToothWave RF utilizing toothbrush
RF-utilizing powered toothbrush for teeth whitening
Other Names:
  • RF toothbrush
Sham Comparator: Control - powered toothbrush
Subject using a regular powered toothbrush with no RF.
regular powered toothbrush with no RF

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Extrinsic Stains
Time Frame: 6 weeks

Extrinsic Stains will be evaluated using the validated Lobene Stain Index (LSI)

Stain Intensity score range is between 0 and 3, where:

0 = no stain

  1. = light stain
  2. = moderate stain
  3. = heavy stain

The mean stain intensity will be calculated for both the gingival and body regions of the incisor teeth for each subject.

Stain Area score rage is between 0 and 3, where:

0 = no stain

  1. = stain covering up to one third of region
  2. = stain covering up to two thirds of region
  3. = stain covering more than two thirds of region

The mean stain area will be calculated for both the gingival and body regions of the incisor teeth for each subject.

6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tooth color assessment
Time Frame: 6 weeks
VITA Bleachedguide 3D-Master shade guide, includes 29 shade levels defined by the American Dental Association (ADA). These shade levels represents the brightness of the tooth where 1 is the whitest and 29 is the darkest shade.
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jeffery L Milleman, DDS, MPA, Salus research center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2019

Primary Completion (Actual)

April 12, 2019

Study Completion (Actual)

April 12, 2019

Study Registration Dates

First Submitted

March 20, 2019

First Submitted That Met QC Criteria

March 20, 2019

First Posted (Actual)

March 21, 2019

Study Record Updates

Last Update Posted (Actual)

September 10, 2019

Last Update Submitted That Met QC Criteria

September 9, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • DO116028A

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tooth Discoloration

Clinical Trials on ToothWave

3
Subscribe